ÂÜÀòÂÒÂ×

Mark Driscoll is the Co-Founder and CSO of Intus Biosciences, where he and his team have developed a groundbreaking platform for bacterial community profiling with strain-level resolution. Prior to Intus Biosciences, Mark served as an International Product Manager at 454 Life Sciences, a Roche company, and as a Group Leader at Molecular Staging Inc. Mark holds a Ph.D. from the University of Rochester School of Medicine and Dentistry and a Bachelor of Science in Biology from the University at Buffalo.